Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc. - ROEverified

TECX

Price:

$30.02

Market Cap:

$566.45M

Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator ...[Read more]

Industry

Biotechnology

IPO Date

2018-06-21

Stock Exchange

NASDAQ

Ticker

TECX

The ROE as of June 2026 (TTM) for Tectonic Therapeutic, Inc. (TECX) is -32.33%

According to Tectonic Therapeutic, Inc.’s latest financial reports and current stock price. The company's current ROE is -32.33%. This represents a change of 294.68% compared to the average of -8.19% of the last 4 quarters.

Tectonic Therapeutic, Inc. (TECX) Historical ROE (quarterly & annually)

How has TECX ROE performed in the past?

The mean historical ROE of Tectonic Therapeutic, Inc. over the last ten years is -67.38%. The current -32.33% ROE has changed -52.03% with respect to the historical average. Over the past ten years (40 quarters), TECX's ROE was at its highest in in the December 2021 quarter at 188.68%. The ROE was at its lowest in in the March 2023 quarter at -47.09%.

Quarterly (TTM)
Annual

Average

-67.38%

Median

-38.58%

Minimum

-554.18%

Maximum

70.49%

Tectonic Therapeutic, Inc. (TECX) ROE by Quarter and Year

Discovering the peaks and valleys of Tectonic Therapeutic, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 425.30%

Maximum Annual ROE = 70.49%

Minimum Annual Increase = -226.78%

Minimum Annual ROE = -554.18%

Quarterly (TTM)
Annual
YearROEChange
2025-29.50%-28.37%
2024-41.19%-181.40%
202350.60%-28.22%
202270.49%18.12%
202159.67%-226.78%
2020-47.07%19.99%
2019-39.23%3.38%
2018-37.94%-93.15%
2017-554.18%425.30%

Tectonic Therapeutic, Inc. (TECX) Average ROE

How has TECX ROE performed in the past?

The current ROE of Tectonic Therapeutic, Inc. (TECX) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.70%

5-year avg

22.01%

10-year avg

-67.38%

Tectonic Therapeutic, Inc. (TECX) ROE vs. Peers

How is TECX’s ROE compared to its peers?

Tectonic Therapeutic, Inc.’s ROE is greater than Alto Neuroscience, Inc. (-47.22%), greater than Larimar Therapeutics, Inc. (-134.14%), greater than Cellectis S.A. (-80.61%), greater than Lyell Immunopharma, Inc. (-85.71%), greater than Amarin Corporation plc (-7.34%), greater than AC Immune S.A. (-123.98%), greater than DBV Technologies S.A. (-130.06%), greater than Alpha Tau Medical Ltd. (-73.23%), greater than Silence Therapeutics plc (-121.71%), greater than Aldeyra Therapeutics, Inc. (-57.34%),

Build a custom stock screener for Tectonic Therapeutic, Inc. (TECX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tectonic Therapeutic, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tectonic Therapeutic, Inc. (TECX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tectonic Therapeutic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Tectonic Therapeutic, Inc.'s ROE?

How is the ROE calculated for Tectonic Therapeutic, Inc. (TECX)?

What is the highest ROE for Tectonic Therapeutic, Inc. (TECX)?

What is the 3-year average ROE for Tectonic Therapeutic, Inc. (TECX)?

What is the 5-year average ROE for Tectonic Therapeutic, Inc. (TECX)?

How does the current ROE for Tectonic Therapeutic, Inc. (TECX) compare to its historical average?